DCCPS By The Numbers

As a window into the many ways DCCPS provides return on investment, we highlight here some snapshots of progress over the year.


Since the Automated Self-Administered 24-Hour (ASA24®) Dietary Assessment Tool was released in 2009, researchers have collected 898,332 dietary recalls or food records. On average in fiscal year (FY) 2023, 530 studies per month used ASA24 to collect dietary data, and 145 new studies registered each month to use ASA24. As of September 2023, more than 800 peer-reviewed scientific publications cited the use of ASA24 to collect dietary data.

77 Million

The Annual Report to the Nation on the Status of Cancer, Part 2, highlighted findings on changes in cancer diagnoses in the United States during the first year of the COVID-19 pandemic. The findings suggest that many cancers were not being diagnosed in a timely manner during the early part of the pandemic, likely due to interruptions in medical care. The report garnered more than 60 stories in the media, reaching an audience of more than 335,000 people. Total impressions—or the number of times a particular news article has been viewed—were measured at 77 million from all media coverage.


The Cancer Epidemiology Descriptive Cohort Database (CEDCD) contains descriptive information from over 60 cohorts, with participants from 20 different countries. CEDCD includes brief descriptions of the cohorts, contact information, questionnaires, types of data collected, enrollment numbers, number of cancer cases, and number of biospecimens collected. Its purpose is to foster collaboration and encourage cohort-based research. In the past year, CEDCD was accessed more than 3,000 times, with over 2,500 new users.


SEER-CAHPS links data from Surveillance, Epidemiology and End Results (SEER), Medicare enrollment data, Medicare claims, and Medicare Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys of the patients’ experience with their care. SEER registry and Medicare claims data have been linked with CAHPS survey data through 2019, yielding more than 562,000 respondents with cancer, and more than 1.3 million respondents without cancer living in a SEER region. The next scheduled data update will occur in early 2025, for data through 2021.

1.2 Million

SEER-MHOS (Medicare Health Outcomes Survey) is one of the largest US population-based cohorts that provides information about cancer health outcomes and quality of life. This data resource contains over 1.2 million survey respondents. Updated data linkages between SEER, Medicare enrollment, Part D enrollment and claims, and the MHOS are now available, with data through 2021.


In FY 2023, there were 2,285 webinar attendees for NCI Office of Cancer Survivorship’s (OCS) events, including webinars in the OCS Director’s Series, the New Investigators Series, and funding opportunity presentations.

$50 Million

NCI awarded $50 million over 5 years to five Centers for Cancer Control Research in Persistent Poverty Areas across nine states. The initiative aims to alleviate the cumulative effects of persistent poverty on cancer outcomes by building research capacity, fostering cancer prevention research, and promoting the implementation of community-based programs.


In the 20 years since its inception, more than 14,000 data users have utilized the Health Information National Trends Survey® (HINTS), which monitors changes in the rapidly evolving fields of health communication and health information technology. As of September 2023, 845 publications in 284 peer-reviewed journals had used data from the nationally representative, public-use HINTS data sets.


Across 16 survey administrations, HINTS has surveyed more than 63,000 American adults, tracking shifts in the communication landscape and information support needs in the population.


In FY 2023, DCCPS hosted over 50 fellows from various training mechanisms, including Cancer Research Training Awardees, Cancer Prevention Fellows, summer interns, University of Maryland semester interns, iCure Fellows, Presidential Management Fellows, and Management Interns.

11 Million

Population-based Research to Optimize the Screening Process (PROSPR) is an NCI-funded research network that consists of 10 diverse healthcare delivery systems across the United States. The PROSPR cohort includes approximately 11 million individuals. The data were collected to investigate the screening processes for three cancers: cervical, colorectal, and lung. Researchers may request access to PROSPR data through PROSPR DataShare.


In FY 2023, OCS shared an additional five new cancer survivor stories on its Cancer Survivor Stories webpage. The page had over 11,000 page views by 6,940 visitors.


The Federal Cervical Cancer Collaborative (FCCC), stemming from the Cancer MoonshotSM initiative, focuses on underserved groups to improve cervical cancer screening, follow-up, and referrals for care. Collaborating with partners in DCCPS, the FCCC has played a key role in the development of a provider toolkit for use in safety-net settings of care. Between May and August 2023, the FCCC toolkit had 2,028 views among 1,381 active users.


Twenty-five early-stage investigators participated in the 2023 Implementation Science Centers in Cancer Control (ISC3) Annual Grantee Meeting, held in Boston, MA.


One-hundred and two pilot projects have been developed by ISC3 since the program’s inception in 2019.


Cancer information seeking is recognized as an important, life-saving behavior. DCCPS analyzed 319,078 inquiries received by NCI’s Cancer Information Service (CIS) from September 2018 through August 2023 to better understand the cancer information-seeking behaviors of the general public, cancer survivors, caregivers, and health professionals. These descriptive analyses provide insights that may help public health agencies deliver, prioritize, and tailor their messaging and responses to specific audiences.


The current sample grant applications published by the Epidemiology and Genomics Research Program (EGRP) were downloaded more than 6,100 times in FY 2023.


In total, 900 cancer survivors will be enrolled in research projects as part of the Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors consortium, a vast collection of behavioral intervention clinical trials testing the effects of exercise and nutrition interventions on cancer treatment-related outcomes.


In FY 2023, there were, on average, 624 individuals registered per webinar in the public-facing Obesity & Cancer webinar series. Webinar topics included physical activity of pediatric cancer survivors, prostate cancer, structural racism, and inflammation.


Since the inception of the Consortium for Cancer Implementation Science (CCIS) in 2019, 33 tools and resources (“public goods”) have been developed through the consortium to support cancer implementation science.

3.4 Million

In FY 2023, 3.4 million people visited Smokefree.gov to access evidence-based information, interactive digital tools, and encouragement for assistance in quitting cigarettes, e-cigarettes, and other tobacco products.


In FY 2023, Smokefree.gov was visited by people from every state across the United States and 186 countries around the world. Smokefree.gov provides millions of people each year with information and digital tools to help them quit using tobacco products.


The database of Genotypes and Phenotypes (dbGaP) at the National Center for Biotechnology Information archives data sets and makes them available to the scientific community. As of September 2023, 94 data sets from DCCPS-funded studies can be accessed through dbGaP.


The Healthy Eating Index (HEI) is a scoring metric that can be used to determine overall diet quality, as well as the quality of several dietary components. Since the first version of the HEI was released in 2008, researchers have used HEI in 783 publications. A total of 902 people registered for a September 2023 webinar to learn about two new iterations of the HEI: HEI-2020 and HEI-Toddlers-2020.


In FY 2023, 11,861 Evidence-Based Cancer Control Programs resources were downloaded, providing program planners and public health practitioners access to research materials to implement in community and clinical practice.


There was a sustained increase in the number of health disparities and health equity grants within the division’s overall portfolio. In FY 2023, 76% of the division’s funded awards included a health disparities component.


The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics to help reduce the cancer burden among the US population. Since 1975, researchers have used SEER data for their primary analysis in more than 21,000 publications.

23 Million

The SEER website had almost 23 million page views in FY 2023.

Continue To

Additional Information